These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6345121)

  • 21. [Biguanides: reasons for withdrawal of drugs and remaining indications].
    Bolzano K
    Acta Med Austriaca; 1978; 5(3):85-8. PubMed ID: 752219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Glibenclamide, a new oral antidiabetic].
    Edlén A
    Lakartidningen; 1972 Jan; 69(4):342-3. PubMed ID: 4622487
    [No Abstract]   [Full Text] [Related]  

  • 23. Obesity and diabetes.
    Kautzky-Willer A; Lemmens-Gruber R
    Handb Exp Pharmacol; 2012; (214):307-40. PubMed ID: 23027457
    [No Abstract]   [Full Text] [Related]  

  • 24. Lactic acidotic coma with multiple medication including metformin in a patient with normal renal function.
    Ryder RE
    Br J Clin Pract; 1984 Jun; 38(6):229-30, 232. PubMed ID: 6743501
    [No Abstract]   [Full Text] [Related]  

  • 25. Lactic acidosis during metformin treatment in an elderly diabetic patient with impaired renal function.
    Hermann LS; Magnusson S; Möller B; Casey C; Tucker GT; Woods HF
    Acta Med Scand; 1981; 209(6):519-20. PubMed ID: 7257870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Behavior of lactate and pyruvate in diabetics during ambulatory treatment with biguanides or with a combination of biguanides and sulfonylureas. II].
    Lunetta M; Presti C; Mughini MT; Mughini L
    Clin Ter; 1980 Jun; 93(6):657-72. PubMed ID: 6775864
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of treatment with glipizide-metformin on the behavior of blood sugar, insulin and lipids after intravenous administration of glucose in diabetic subjects].
    Ferlito S; Lunetta M; Mangiagli P; Tranchida ML
    G Clin Med; 1974 Nov; 55(11):798-818. PubMed ID: 4469884
    [No Abstract]   [Full Text] [Related]  

  • 28. [Insulin plus sulfonyl urea--a(n) (im)possible combination?].
    Bachmann W
    Dtsch Med Wochenschr; 1982 Feb; 107(5):163-5. PubMed ID: 7035120
    [No Abstract]   [Full Text] [Related]  

  • 29. Metformin and other antidiabetic agents in renal failure patients.
    Lalau JD; Arnouts P; Sharif A; De Broe ME
    Kidney Int; 2015 Feb; 87(2):308-22. PubMed ID: 24599253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fatal case of metformin-induced lactic acidosis after urography in a diabetic patient (author's transl)].
    Jamet P; Lebas de Lacour JC; Christoforov B; Stern M
    Sem Hop; 1980 Mar 8-15; 56(9-10):473-4. PubMed ID: 6244670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [10 cases of lactic acidosis during biguanide therapy (buformin and phenformin)].
    Berger W; Mehnert-Aner S; Mülly K; Heierli C; Ritz R
    Schweiz Med Wochenschr; 1976 Dec; 106(50):1830-4. PubMed ID: 1013709
    [No Abstract]   [Full Text] [Related]  

  • 32. Metformin.
    Bailey CJ; Turner RC
    N Engl J Med; 1996 Feb; 334(9):574-9. PubMed ID: 8569826
    [No Abstract]   [Full Text] [Related]  

  • 33. Overview of current therapeutic options in type 2 diabetes. Rationale for combining oral agents with insulin therapy.
    Buse JB
    Diabetes Care; 1999 Apr; 22 Suppl 3():C65-70. PubMed ID: 10189565
    [No Abstract]   [Full Text] [Related]  

  • 34. [Sulfonylurea compounds or biguanides in the treatment of type 2 diabetes?].
    Mehnert H
    Dtsch Med Wochenschr; 1989 Jul; 114(27):1086-8. PubMed ID: 2500320
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experience with phenformin in combination with insulin or oral antidiabetic drugs in ambulatory diabetic patients].
    Stratmann FW
    Med Welt; 1976 Feb; 27(6):273-6. PubMed ID: 768703
    [No Abstract]   [Full Text] [Related]  

  • 36. [Controversial aspects regarding metformin in type 2 diabetic patient: reduction of late complications in early, single drug administration; increased risk of death in later administration in combination with sulfonylurea compounds].
    Ritzmann P
    Praxis (Bern 1994); 1999 Aug; 88(33):1330-1. PubMed ID: 10483287
    [No Abstract]   [Full Text] [Related]  

  • 37. [Insulin receptors and interference by medication: in vivo and in vitro studies].
    Canivet B; Dolais-Kitabgi J; Freychet P
    Journ Annu Diabetol Hotel Dieu; 1982; ():61-70. PubMed ID: 7047843
    [No Abstract]   [Full Text] [Related]  

  • 38. Lactic acidosis through medicaments.
    Walker RS
    Helv Med Acta; 1970 Dec; 35(5):448-55. PubMed ID: 4993591
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparison of metformin versus guar in combination with sulphonylureas in the treatment of non insulin dependent diabetes.
    Wilson JA; Scott MM; Gray RS
    Horm Metab Res; 1989 Jun; 21(6):317-9. PubMed ID: 2777189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of poorly controlled type 2 diabetes.
    Peters AL; Davidson MB
    Compr Ther; 1994; 20(6):321-5. PubMed ID: 8062539
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.